DNA copy number changes in thyroid carcinoma

American Journal of Pathology

Volumn 154, Issue 5, 1999, Pages 1539-1547

  Hemmer, Samuli ^a,b   Wasenius, Veli Matti ^a   Knuutila, Sakari ^b   Franssila, Kaarle ^a   Joensuu, Heikki ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CYTOGENETICS; DNA DETERMINATION; DNA SEQUENCE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SEQUENCE ANALYSIS; THYROID CARCINOMA;

EID: 0032962377     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65407-7     Document Type: Article

References (53)

1. Franssila K: Thyroid, Bloodworth's Endocrine Pathology ed 3. Edited by Lechago J, Gould VE, Baltimore, Williams & Wilkins, 1997, pp 171-247
2. Demeter JG, De Jong SA, Lawrence AM, Paloyn E: Anaplastic thyroid carcinoma: risk factors and outcome. Surgery 1991, 110:956-963
3. Nel CJ, van Heerden JA, Goellner JR, Gharib H, McConahey WM, Taylor WF, Grant CS: Anaplastic carcinoma of the thyroid: a clinico-pathologic study of 82 cases. Mayo Clin Proc 1985, 60:51-58
4. Mulligan LM, Kwok JB, Healey CS, Elsdon MJ, Eng C, Gardner E, Love DR, Mole SE, Moore JK, Papi L, Ponder MA, Telenius H, Tunnacliffe A, Ponder BAJ: Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature 1993, 363:458-460
5. Carlson KM, Dou S, Chi D, Scavarda N, Toshima K, Jackson CE, Wells SA Jr, Goodfellow PJ, Donis-Keller H: Single missense mutation in the tyrosine kinase catalytic domain of the RET protooncogene is associated with multiple endocrine neoplasia type 2B. Proc Natl Acad Sci USA 1994, 91:1579-1583
6. Blaugrund JE, Johns MM Jr, Eby YJ, Ball DW, Baylin SB, Hruban RH, Sidransky D: RET proto-oncogene mutations in inherited and sporadic medullary thyroid cancer. Hum Mol Genet 1994, 3:1895-1897
7. Mulligan LM, Ponder BA: Genetic basis of endocrine disease multiple endocrine neoplasia type 2. J Clin Endocrinol Metab 1995, 80:1989-1995
8. Wurster-Hill DH, Noll WW, Bircher LY, Pettengill OS, Grizzle WA: Cytogenetics of medullary carcinoma of the thyroid. Cancer Genet Cytogenet 1986, 20:247-253
9. Tanaka K, Baylin SB, Nelkin BD, Testa JR: Cytogenetic studies of a human medullary thyroid carcinoma cell line. Cancer Genet Cytogenet 1987, 25:27-35
10. Babu VR, Van Dyke DL, Flejter WL, Jackson CE: Chromosome 20 deletion in multiple endocrine neoplasia type 2: expanded double-blind studies. Am J Med Genet 1987, 27:739-748
11. Bondeson L, Bengtsson A, Bondeson A-G, Dahlenfors R, Grimelius L, Wedell B, Mark J: Chromosome studies in thyroid neoplasia. Cancer 1989, 64:680-685
12. Jenkins RB, Hay ID, Herath JF, Schultz CG, Spurbeck JL, Grant CS, Goellner JR, Dewald GW: Frequent occurrence of cytogenetic abnormalities in sporadic nonmedullary thyroid carcinoma. Cancer 1990, 66:1213-1220
13. Teyssier J-R, Liautaud-Roger F, Ferre D, Patey M, Dufer J: Chromosomal changes in thyroid tumours: relation with DNA content, karyotypic features, and clinical data. Cancer Genet Cytogenet 1990, 50:249-263
14. Herrmann MA, Hay ID, Bartelt DH Jr, Ritland SR, Dahl RJ, Grant CS, Jenkins RB: Cytogenetic and molecular genetic studies of follicular and papillary thyroid cancers. J Clin Invest 1991, 88:1596-1604
15. Herrmann ME, Mohamed A, Talpos G, Wolman SR: Cytogenetic study of a papillary thyroid carcinoma with a rearranged chromosome 10. Cancer Genet Cytogenet 1991, 57:209-217
16. Antonini P, Vénuat A-M, Caillou B, Berger R, Schlumberger M, Bernheim A, Parmentier C: Cytogenetic studies on 19 papillary thyroid carcinomas. Genes Chromosomes & Cancer 1992, 5:206-211
17. Sozzi G, Bongarzone I, Miozzo M, Cariani CT, Mondellini P, Calderone C, Pilotti S, Pierotti MA, Della Porta G: Cytogenetic and molecular genetic characterization of papillary thyroid carcinomas. Genes Chromosomes & Cancer 5:212-218
18. Roque L, Clode AL, Gomes P, Rosa-Santos J, Scares J, Castedo S: Cytogenetic findings in 31 papillary thyroid carcinomas. Genes Chromosomes & Cancer 1995, 13:157-162
19. Lehmann L, Greulich KM, Zitzelsberger H, Negele T, Spelsberg F, Bauchinger M, Weier HUG: Cytogenetic and molecular genetic characterization of a chromosome 2 rearrangement in a case of human papillary thyroid carcinoma with radiation history. Cancer Genet Cytogenet 1997, 96:30-36
20. Grieco M, Santoro M, Berlingieri MT, Melillo RM, Donghi R, Bongarzone I, Pierotti MA, Della Porta G, Fusco A, Vecchio G: PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas. Cell 1990, 60:557-563
21. Di Renzo MF, Olivero M, Ferro S, Prat M. Bongarzone I, Pilotti S, Belfiore A, Constantino A, Vigneri R, Pierotti MA, Comoglio PM: Overexpression of the c-MET/HGF receptor gene in human thyroid carcinomas. Oncogene 1992, 7:2549-2553
22. Bongarzone I, Pierotti MA, Monzini N, Mondellini P, Manenti G, Donghi R, Pilotti S, Grieco M, Santoro M, Fusco A, Vecchio G, Della Porta G: High frequency of activation of tyrosine kinase oncogenes in human papillary thyroid carcinoma. Oncogene 1989, 4:1457-1462
23. Santoro M, Dathan NA, Berlingieri MT, Bongarzone I, Paulin C, Grieco M, Pierotti MA, Vecchio G, Fusco A: Molecular characterization of RET/PTC3, a novel rearranged version of the RET proto-oncogene in human thyroid papillary carcinoma. Oncogene 1994, 9:509-516
24. van den Berg E, van Doormaal JJ, Oosterhuis JW, de Jong B, Wiersema J, Vos AM, Dam A, Vermeij A: Chromosomal aberrations in follicular thyroid carcinoma: case report of a primary tumor and its metastasis. Cancer Genet Cytogenet 1991, 54:215-222
25. Roque L, Castedo S, Clode A, Soares J: Deletion of 3p25-pter in a primary follicular thyroid carcinoma and its metastasis. Genes Chromosomes & Cancer 1993, 8:199-203
26. Grebe SKG, McIver B, Hay ID, Wu PSC, Maciel LMZ, Drabkin HA, Goellner JR, Grant CS, Jenkins RB, Eberhardt NL: Frequent loss of heterozygosity on chromosomes 3p and 17p without VHL or p53 mutations suggests involvement of unidentified tumor suppressor genes in follicular thyroid carcinoma. J Clin Endocrinol Metab 1997, 82:3684-3691
27. Hemmer S, Wasenius V-M, Knuutila S, Joensuu H, Franssila K: Comparison of benign and malignant follicular thyroid tumours by comparative genomic hybridization. Br J Cancer 1998, 78:1012-1017
28. Mark J, Ekedahl C, Dahlenfors R, Westermark B: Cytogenetical observations in five anaplastic thyroid carcinomas. Hereditas 1987, 107:163-174
29. Ito T, Seyama T, MizunoT, Tsuyama N, Hayashi T, Hayashi Y, Dohi K, Nakamura N, Akiyma M: Unique association of p53 mutations with undifferentiated but not with differentiated carcinomas of the thyroid gland. Cancer Res 1992, 52:1369-1371
30. Isola JJ, de Vries S, Chu LW, Ghazvini S, Waldman FM: Analysis of changes in DNA sequence copy number by comparative genomic hybridization in archival paraffin-embedded tumor samples. Am J Pathol 1994, 145:1301-1308
31. Hedinger C, Williams ED, Sobin LH: The WHO histological classification of thyroid tumours: a commentary on the second edition. Cancer 1989, 63:908-911
32. Union Internationale Contre le Cancer: TNM Classification of Malignant Tumours, ed 4. Berlin, Springer-Verlag, 1987
33. Sambrook J, Fritsch EF, Maniatis T: Molecular Cloning: A Laboratory Manual, ed 2. Cold Spring Harbor, NY, Cold Spring Harbor Laboratory Press, 1989
34. Kallioniemi O-P, Kallioniemi A, Piper J, Isola J, Waldman FM, Gray JW, Pinkel D: Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumour. Genes Chromosomes & Cancer 1994, 10:231-243
35. El-Rifai W, Larramendy ML, Björkqvist A-M, Hemmer S, Knuutila S: Optimization of comparative genomic hybridization by fluorochrome conjugated to dCTP and dUTP nucleotides. Lab Invest 1997, 77:699-700
36. Kuukasjärvi T, Tanner M, Pennanen S, Karhu R, Visakorpi T, Isola J: Optimizing DOP-PCR for universal amplification of small DNA samples in comparative genomic hybridization. Genes Chromosomes & Cancer 1997, 18:94-101
37. Tapper J, Sarantaus L, Vahteristo P, Nevanlinna H, Hemmer S, Seppälä M, Knuutila S, Butzow R: Genetic changes in inherited and sporadic ovarian carcinomas by comparative genomic hybridization: extensive similarity except for a difference at chromosome 2q24-q32. Cancer Res 1998, 58:2715-2719
38. Antonini P, Vénuat A-M, Linares G, Caillou, Berger R, Parmentier C: A translocation (7;10)(q35;q21) in a differentiated papillary carcinoma of the thyroid. Cancer Genet Cylogenet 1989, 41:139-144
39. Olah E, Balogh E, Bojan F, Juhasz F, Stenszky V, Farid N: Cytogenetic analyses of three papillary carcinomas and a follicular adenoma of the thyroid. Cancer Genet Cytogenet 1990, 44:119-129
40. Sozzi G, Bongarzone I, Miozzo M, Borello MG, Butti MG, Pilotti S, Della Porta G, Pierotti MA: A t(10;17) translocation creates the RET/PTC2 chimeric transforming sequence in papillary thyroid carcinoma. Genes Chromosomes & Cancer 1994, 9:244-250
41. Franssila K: Value of histologic classification of thyroid cancer. Acta Pathol Microbiol Scand A 1971, 225:1-76
42. Joensuu H, Klemi P, Eerola E, Tuominen J: Influence of cellular DNA content on survival in differentiated thyroid cancer. Cancer 1986, 58:2462-2467
43. Tonk V, Osella P, Delasmorenas A, Wyandt HE, Milunsky A: Abnormalities of chromosome 22 in meningiomas and confirmation of the origin of a dicentric 22 by in situ hybridization. Cancer Genet Cytogenet 1992, 64:65-68
44. Björkqvist A-M, Tammilehto L, Anttila S, Mattson K, Knuutila S: Recurrent DNA copy number changes in 1q, 4q, 6q, 9p, 13q, 14q, and 22q detected by comparative genomic hybridization in malignant mesothelioma. Br J Cancer 1997, 75:523-527
45. Ruttledge M, Sarrazin J, Rangaratnam S, Phelan C, Twist E, Merel P, Delattre O, Thomas G, Nordenskjöld M, Collins P, Dumanski J, Rouleau G: Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas. Nature Genet 1994, 6:180-184
46. Schofield DE, Beckwith JB, Sklar J: Loss of heterozygosity at chromosome regions 22q11-12 and 11p15.5 in renal rhabdoid tumours. Genes Chromosomes & Cancer 1996, 15:10-17
47. Mitelman F, Mertens F, Johansson B: A breakpoint map of recurrent chromosomal rearrangements in human neoplasia. Nature Genet 1997, 15:417-474
48. Tirkkonen M, Tanner M, Karhu R, Kallioniemi A, Isola J, Kallioniemi O-P: Molecular cytogenetics of primary breast cancer by CGH. Genes Chromosomes & Cancer 1998, 21:177-184
49. Petersen I, Langreck H, Wolf G, Schwendel A, Psille R, Vogt P, Reichel MB, Ried T, Dietel M: Small-cell lung cancer is characterized by a high incidence of deletions on chromosomes 3p, 4q, 5q, 10q, 13q and 17p. Br J Cancer 1997, 75:79-86
50. Mertens F, Johansson B, Höglund M, Mitelman F: Chromosomal imbalance maps of malignant solid tumors: a cytogenetic survey of 3185 neoplasms. Cancer Res 1997, 57:2765-2780
51. Kallioniemi A, Kallioniemi O-P, Citro G, Sauter G, DeVries S, Kerschmann R, Caroll P, Waldman F: Identification of gains and losses of DNA sequences in primary bladder cancer by comparative genomic hybridization. Genes Chromosomes & Cancer 1995, 12; 213-219
52. Monni O, Joensuu H, Franssila K, Knuutila S: DNA copy number changes in diffuse large B-cell lymphoma: comparative genomic hybridization study. Blood 1996, 87:5269-5278
53. Wurster-Hill DH, Pettengill OS, Noll WW, Gibson SH, Brinck-Johnsen T: Hypodiploid, pseudodiploid, and normal karyotypes prevail in cytogenetic studies of medullary carcinomas of the thyroid and metastatic tissues. Cancer Genet Cytogenet 1990, 47:227-241